Revatio for Heart Disease in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy (REVERSE-DBMD)
Phase 2 Clinical Trial of Sildenafil for Cardiac Dysfunction in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Terminated
As recommended by the DSMB.
Other terminated trials from Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Acquired Brain Injury · Phase NA · Jan 2024
- Spinal Cord Injury · Phase PHASE1/PHASE2 · Jan 2021
- Spinal Cord Injury · Phase NA · Mar 2018
- Adrenoleukodystrophy · Phase PHASE2 · Dec 2014
- Spinal Cord Injury · Phase PHASE2/PHASE3 · Aug 2013
More terminations from Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
This PHASE2 trial investigates Becker Muscular Dystrophy and Duchenne Muscular Dystrophy and is currently terminated or withdrawn. Hugo W. Moser Research Institute at Kennedy Krieger, Inc. leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Mar 2019 [monthly]
Terminated PHASE2
-
Apr 2018 — Jun 2018 [monthly]
Terminated PHASE2
Status: Suspended → Terminated
-
Jan 2017 — Apr 2018 [monthly]
Suspended PHASE2
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Johns Hopkins University
For direct contact, visit the study record on ClinicalTrials.gov .